Bruker (BRKR) Raw Materials (2010 - 2026)

Bruker (BRKR) has reported Raw Materials for 17 consecutive years, with $395.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Raw Materials fell 7.49% year-over-year to $395.4 million; the trailing twelve-month figure through Jun 2026 stood at $395.4 million (down 7.49% YoY), and the FY2025 full-year result was $392.0 million, up 0.85% from the prior year.
• Raw Materials rose to $395.4 million in Q2 2026 per BRKR's latest filing, from $393.4 million in the prior quarter.
• Across five years, Raw Materials topped out at $434.3 million in Q3 2024 and bottomed at $238.8 million in Q1 2022.
• Historically, Raw Materials has averaged $360.0 million across 5 years, with a median of $390.3 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Raw Materials soared 37.59% in 2022, then decreased 7.49% in 2026.
• Over 5 years, Raw Materials stood at $300.9 million in 2022, then advanced by 23.36% to $371.2 million in 2023, then climbed by 4.71% to $388.7 million in 2024, then advanced by 0.85% to $392.0 million in 2025, then advanced by 0.87% to $395.4 million in 2026.
• According to Business Quant data, Raw Materials over the past three periods registered $395.4 million, $393.4 million, and $392.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.